Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Clinical Utility Study

April 8, 2021
RNS Number : 7571U Renalytix AI PLC 08 April 2021       Renalytix AI plc   (" RenalytixAI " or the " Company ")     Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions   Value of KidneyIntelX Testing Demonstrated by Data from 401

Clinical findings published in Diabetologia

April 6, 2021
RNS Number : 4091U Renalytix AI PLC 06 April 2021       Renalytix AI plc   (" RenalytixAI " or the " Company ")     Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure  

Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure

April 5, 2021
Clinical findings published in the April issue of Diabetologia, the official journal of the European Association for the Study of Diabetes NEW YORK, April 05, 2021 (GLOBE NEWSWIRE) -- RenalytixAI plc (LSE: RENX) (NASDAQ: RNLX), announced today that KidneyIntelX™  more accurately predicted

Update on Finalization of MCIT Rule

March 15, 2021
RNS Number : 1874S Renalytix AI PLC 15 March 2021   Renalytix AI plc (" RenalytixAI " or the " Company ")   Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics   NEW YORK , March 15, 2021 - Renalytix AI plc   (LSE : RENX) (NASDAQ:

Issue of shares, PDMR Dealing and TVR

March 4, 2021
RNS Number : 2460R Renalytix AI PLC 04 March 2021     Renalytix AI plc ("RenalytixAI", the "Company" or the "Group")   Issue of shares under the 2020 Employee Share Purchase Plan, PDMR Dealing and Total Voting Rights   New York , 4 March 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX),, an

Financial Results for Second Quarter of FY 2021

March 2, 2021
RNS Number : 8363Q Renalytix AI PLC 02 March 2021   RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021   NEW YORK , March 2, 2021   - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX) ("RenalytixAI" or the "Company"), an artificial intelligence-enabled in vitro diagnostics
Displaying 1 - 10 of 169